- TRADE NAMES: Clom 50; Clomid (Sanofi-Aventis); Clomifen; Dyneric; Milophene; Omifin; Pergotime; Phenate; Serophene (Merck)
- INDICATIONS:
Ovulatory failure.
Used in the treatment of hypogonadism, especially in men of reproductive age.
- CLASS: Selective estrogen receptor modulator (SERM)
- HALF-LIFE: 5–7 days
- CLINICALLY IMPORTANT, POTENTIALLY HAZARDOUS INTERACTIONS WITH:
None known
- See adverse reactions attributed to class:
Please login to view the rest of this drug profile.
Click on the DRUG REVIEW ARTICLE tab (above) to see a review of clomiphene in the Taylor & Francis journal Expert Opinion on Drug Safety.
(Note that non-subscribers to the journal will only be able to see an abstract of the article.)
Page last updated 12/15/2024
